We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIOAU
5351
DELISTED
Tio Tech A Units
TIOAU
$2K ﹤0.01%
197
+98
+99% +$976
CIH
5352
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$2K ﹤0.01%
+1,412
New +$2.23K
ARVL
5353
DELISTED
Arrival Ordinary Shares
ARVL
$2K ﹤0.01%
4
-9
-69% -$5.75K
GLS
5354
DELISTED
Gelesis Holdings, Inc.
GLS
$2K ﹤0.01%
220
+130
+144% +$1.28K
QTT
5355
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$2K ﹤0.01%
175
+52
+42% +$747
GXIIU
5356
DELISTED
GX Acquisition Corp. II Unit
GXIIU
$2K ﹤0.01%
200
PTOC
5357
DELISTED
Pine Technology Acquisition Corp. Class A Common Stock
PTOC
$2K ﹤0.01%
+172
New +$1.66K
KRBP
5358
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$2K ﹤0.01%
+27
New +$2.79K
FRSG
5359
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$2K ﹤0.01%
+153
New +$1.5K
ABGI
5360
DELISTED
ABG Acquisition Corp. I
ABGI
$2K ﹤0.01%
197
DTRTU
5361
DELISTED
DTRT Health Acquisition Corp. Unit
DTRTU
$2K ﹤0.01%
+166
New +$1.67K
PFHD
5362
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$2K ﹤0.01%
100
-650
-87% -$12.4K
EXN
5363
DELISTED
Excellon Resources Inc.
EXN
$2K ﹤0.01%
+1,320
New +$2.49K
AYLA
5364
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$2K ﹤0.01%
163
-307
-65% -$3.68K
PACXU
5365
DELISTED
Pioneer Merger Corp. Unit
PACXU
$2K ﹤0.01%
195
+109
+127% +$1.12K
CLAS.U
5366
DELISTED
Class Acceleration Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
CLAS.U
$2K ﹤0.01%
183
MDH
5367
DELISTED
MDH Acquisition Corp.
MDH
$2K ﹤0.01%
+174
New +$1.7K
HCARU
5368
DELISTED
Healthcare Services Acquisition Corporation Unit
HCARU
$2K ﹤0.01%
+200
New +$2K
OSTRU
5369
DELISTED
Oyster Enterprises Acquisition Corp. Unit
OSTRU
$2K ﹤0.01%
185
GLHA
5370
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
$2K ﹤0.01%
+176
New +$1.7K
AAQC.U
5371
DELISTED
Accelerate Acquisition Corp Units
AAQC.U
$2K ﹤0.01%
170
+160
+1,600% +$1.6K
PHCF
5372
DELISTED
Puhui Wealth Investment Management Co., Ltd.
PHCF
$2K ﹤0.01%
+179
New +$3.54K
VTIQ
5373
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
$2K ﹤0.01%
+240
New +$2.34K
FTCV
5374
DELISTED
FinTech Acquisition Corp. V Class A Common Stock
FTCV
$2K ﹤0.01%
+200
New +$2.11K
CRU.U
5375
DELISTED
Crucible Acquisition Corporation Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
CRU.U
$2K ﹤0.01%
151
-256
-63% -$2.56K

Similar funds

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.